Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

TBPHTBPH
Showing 5 of 8 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in THERAVANCE BIOPHARMA INC

Qube Research & Technologies Ltd holds 289,473 shares of TBPH (THERAVANCE BIOPHARMA INC), worth $4.7M as of 2026-Q1. The position was decreased (-38.9% shares). TBPH represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$4.7M

Current Shares

289,473

Total Value Change

+$3.7M

Total Shares Change

+175,534

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
289,473
-38.9%
$4.7M0.0%$13.96
0
2025-Q4
Increased
473,498
+124.4%
$8.9M0.0%$18.91
44
2025-Q3
Increased
211,048
+2.8%
$3.1M0.0%$14.43
27
2025-Q2
Increased
205,280
+80.2%
$2.3M0.0%$11.22
40
2025-Q1
New
113,939
-
$1M0.0%$9.23
35

Other major holders of TBPH: BAUPOST GROUP LLC/MA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used